MoneyWorks4Me

Zydus Lifesciences informs about press release

13 Jan 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated January 13, 2026, titled ‘Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..